Incidence of Reye's syndrome in France: A hospital-based survey

Journal of Clinical Epidemiology

Volumn 54, Issue 8, 2001, Pages 857-862

  Autret Leca, Elisabeth ^a,e   Jonville Béra, Annie Pierre ^a   Llau, Marie Elise ^a   Bavoux, Françoise ^b   Saudubray, Jean Marie ^c   Laugier, Jean ^a   Devictor, Denis ^d   Barbier, Pascaline ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d BICÊTRE HOSPITAL   (France)

^e CHU BRETONNEAU   (France)

Author keywords

Aspirin; Epidemiology; France; Incidence; Population based survey; Reye syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 5; IBUPROFEN; PARACETAMOL;

ADOLESCENT; AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; BRAIN DISEASE; CEREBROSPINAL FLUID EXAMINATION; CHICKENPOX; CHILD; CONTROLLED STUDY; DANGEROUS GOODS; DRUG LABELING; EUROPE; FRANCE; HEALTH SURVEY; HOSPITAL; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PRIORITY JOURNAL; REYE SYNDROME; RISK; TIME; UNITED STATES; VIRUS INFECTION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; CHILD, PRESCHOOL; DRUG LABELING; FRANCE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; LIVER FUNCTION TESTS; POISSON DISTRIBUTION; POPULATION SURVEILLANCE; REYE SYNDROME;

EID: 0034904815     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00366-8     Document Type: Article

References (25)

1. Encephalopathy and faty degeneration of the viscera: A disease entity in childhood
2. Reye's syndrome and medication use
3. Reye's syndrome and salicylate use
4. Aspirine as a risk factor in Reye's syndrome
5. Public Health Service study on Reye's syndrome and medications. Report of the pilot phase
6. Public Health Service study of Reye's syndrome and medications. Report of the main study
7. New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association
8. The British Paediatric Surveillance Unit
9. Reye's syndrome in the British isles: First annual report of the joint British Paediatric Association and Communicable Disease Surveillance Center surveillance scheme
10. Reye's syndrome in the British Isles: Report for 1990/91 and the first decade of surveillance
11. The changing epidemiology of Reye's Syndrome in the United States: Further evidence for a public health success
12. National patterns of aspirin use and Reye syndrome reporting, United States, 1980 to 1985
13. Reye Syndrome Surveillance - United States, 1989
14. Centers for Disease Control Reye Syndrome Surveillance - United States, 1987 and 1988
15. Reye's syndrome in the United States from 1981 through 1997
16. Medium-chain and long-chain acylCoA dehydrogenase deficiency: Clinical, pathologic and ultrastructural differentiation from Reye's syndrome
17. Reye's syndrome - A reappraisal of diagnosis in 49 presumptive cases
18. Clinical phenotypes: Diagnosis/algorithms
19. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry
20. Necessity of liver biopsy for accurate diagnosis of Reye's syndrome
21. Trends in aspirin, paracetamol and non-steroidal anti-inflammatory drug use in children between 1981 and 1992 in France
22. The relationship of inborn errors of metabolism to Reye's and Reye-like syndromes
23. Whatever happened to Reye's syndrome? Did it every really exist?
24. Recognition and management of fatty acid oxidation defects: A series of 107 patients
25. The role of tandem mass spectometry in the diagnosis of fatty acid oxidation disorders